Obesity affects a large part of the population. Obesity in most cases is an endocrine pathology that is difficult to correct and treat. Today, the treatment of obesity consists of exercise, diet, medication, and invasive surgery. All of these methods, of course, are successful, but they have their drawbacks and limitations. A new procedure has been developed that can be an effective alternative. This is bariatric arterial embolization. Find out how you can control your hunger.
Bariatric embolization of the gastric artery - a method of controlling hunger
This procedure has recently been tested in a pilot study with positive and promising results. One of the authors of the study presented the results of the trial at the annual meeting of the Society for Interventional Radiology in Vancouver, Canada.
Manipulation to embolize the left gastric artery was previously used in medicine as a method of stopping bleeding in an emergency. What happens after gastric artery embolization, knows estet-portal.com. In the process of bariatric arterial embolization, the main artery supplying the fundus of the stomach is blocked. Blockade of an artery is performed by introducing microscopic beads into the bloodstream using a catheter that is inserted into the groin artery.
The mechanism of action of the method for weight loss is associated with the hormone ghrelin. Ghrelin is a hunger hormone that is produced when there is no food in the stomach.
The role of the hormone ghrelin in the development of hunger
According to the feedback mechanism, when the stomach is stretched by food, the hormone ghrelin ceases to be produced. Ghrelin is a peptide hormone that acts on the hypothalamus to induce hunger and prepare the body for food intake. Ghrelin promotes salivation and increases intestinal motility. About 40 hormones in the body are produced to restrict food intake, and only ghrelin stimulates appetite.
Bariatric arterial embolization, by reducing the blood supply to the fundus of the stomach, reduces the release of ghrelin and reduces the feeling of hunger.
A pilot study was conducted in 7 young patients with a body mass index of 40-50. In all other respects, the health status of the participants was determined to be satisfactory.
During the study, all participants were followed up at 1, 3 and 6 months according to the following criteria:
- ghrelin level;
- weight loss;
- hunger level;
- adverse events and side effects.
Results of a study on the reduction and control of hunger
All patients showed weight loss, reduced hunger and no side effects. The average weight loss after six months of testing was 13.3%, which is a satisfactory result. Ghrelin levels dropped an average of 17.5% after 3 months.
Bariatric arterial embolization is therefore a minimally invasive, safe and effective procedure for reducing hunger and can treat obesity. At the moment, research is ongoing to improve the methodology and its widespread implementation in practice. It is believed that patients who find it difficult to lose weight through exercise and diet can be controlled by this method.
Share:
Add a comment